Jorge Chaves

Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia

John C. Byrd, Bonnie K. Harrington, Susan O’Brien et al. · New England Journal of Medicine · 2015 · 878 citations · Full text

Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer

Mary L. Disis, Matthew H. Taylor, Karen Kelly et al. · JAMA Oncology · 2019 · 417 citations · Full text

Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 results

John C. Byrd, William G. Wierda, Anna Schuh et al. · Blood · 2019 · 172 citations · Full text

Tucatinib with capecitabine and trastuzumab in advanced HER2-positive metastatic breast cancer with and without brain metastases: a non-randomised, open-label, phase 1b study

Rashmi K. Murthy, Virginia F. Borges, Alison Conlin et al. · The Lancet Oncology · 2018 · 171 citations

Breast Oncology, Oncology, Brain Metastases +6

Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study

Funda Meric‐Bernstam, Muralidhar Beeram, Erika Hamilton et al. · The Lancet Oncology · 2022 · 164 citations · Full text